Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Kang HA, Barner JC, Richards KM, Bhor M, Paulose J, Kutlar A. Association Between Vaso-Occlusive Crises and Opioid Prescriptions Among Patients with Sickle Cell Disease: A Retrospective Claims-Based Study. J Health Econ Outcomes Res. 2020;7(1):94-101.
2. Ballas SK. Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic. J Clin Med. 2021;10(3).
3. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033-48.
4. Carroll CP. Opioid treatment for acute and chronic pain in patients with sickle cell disease. Neurosci Lett. 2020;714:134534.
5. Carroll CP, Lanzkron S, Haywood C, Jr., et al. Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease. Am J Prev Med. 2016;51(1 Suppl 1):S69-77.